A detailed history of Us Bancorp \De\ transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 4,426 shares of EDIT stock, worth $5,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,426
Previous 1,203 267.91%
Holding current value
$5,532
Previous $5,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$3.39 - $5.96 $10,925 - $19,209
3,223 Added 267.91%
4,426 $15,000
Q2 2024

Aug 06, 2024

BUY
$4.67 - $7.28 $364 - $567
78 Added 6.93%
1,203 $5,000
Q1 2024

May 07, 2024

BUY
$7.03 - $11.07 $2,172 - $3,420
309 Added 37.87%
1,125 $8,000
Q4 2023

Feb 09, 2024

SELL
$6.25 - $11.11 $5,550 - $9,865
-888 Reduced 52.11%
816 $8,000
Q3 2023

Nov 03, 2023

SELL
$6.92 - $9.31 $602 - $809
-87 Reduced 4.86%
1,704 $13,000
Q2 2023

Aug 09, 2023

SELL
$6.36 - $11.47 $2,868 - $5,172
-451 Reduced 20.12%
1,791 $14,000
Q1 2023

May 09, 2023

BUY
$7.03 - $11.53 $7,718 - $12,659
1,098 Added 95.98%
2,242 $16,000
Q4 2022

Feb 13, 2023

SELL
$8.32 - $13.21 $9,975 - $15,838
-1,199 Reduced 51.17%
1,144 $10,000
Q3 2022

Oct 27, 2022

SELL
$12.16 - $19.42 $9,326 - $14,895
-767 Reduced 24.66%
2,343 $29,000
Q2 2022

Aug 01, 2022

SELL
$9.99 - $21.35 $95,794 - $204,725
-9,589 Reduced 75.51%
3,110 $37,000
Q1 2022

May 11, 2022

BUY
$14.08 - $27.63 $21,401 - $41,997
1,520 Added 13.6%
12,699 $243,000
Q4 2021

Feb 11, 2022

SELL
$26.55 - $40.57 $225,887 - $345,169
-8,508 Reduced 43.22%
11,179 $296,000
Q3 2021

Nov 10, 2021

BUY
$39.27 - $72.94 $373,654 - $694,024
9,515 Added 93.54%
19,687 $809,000
Q2 2021

Aug 05, 2021

SELL
$31.29 - $56.64 $92,649 - $167,711
-2,961 Reduced 22.55%
10,172 $577,000
Q1 2021

Apr 28, 2021

BUY
$39.71 - $90.58 $158,840 - $362,320
4,000 Added 43.8%
13,133 $551,000
Q4 2020

Feb 04, 2021

BUY
$27.07 - $84.35 $135,404 - $421,918
5,002 Added 121.08%
9,133 $641,000
Q3 2020

Nov 10, 2020

SELL
$28.06 - $37.16 $79,437 - $105,199
-2,831 Reduced 40.66%
4,131 $116,000
Q2 2020

Aug 07, 2020

SELL
$18.5 - $34.34 $261,738 - $485,842
-14,148 Reduced 67.02%
6,962 $205,000
Q1 2020

May 13, 2020

BUY
$14.88 - $32.78 $7,440 - $16,390
500 Added 2.43%
21,110 $419,000
Q4 2019

Feb 04, 2020

BUY
$19.49 - $32.63 $367,678 - $615,564
18,865 Added 1081.09%
20,610 $610,000
Q3 2019

Nov 08, 2019

BUY
$22.49 - $26.81 $12,257 - $14,611
545 Added 45.42%
1,745 $39,000
Q2 2019

Aug 13, 2019

SELL
$20.48 - $27.76 $4,710 - $6,384
-230 Reduced 16.08%
1,200 $30,000
Q1 2019

May 08, 2019

BUY
$19.43 - $26.41 $9,326 - $12,676
480 Added 50.53%
1,430 $35,000
Q3 2018

Nov 01, 2018

SELL
$27.65 - $38.39 $5,530 - $7,678
-200 Reduced 17.39%
950 $30,000
Q2 2018

Aug 08, 2018

SELL
$31.4 - $41.01 $14,789 - $19,315
-471 Reduced 29.06%
1,150 $41,000
Q1 2018

May 08, 2018

BUY
$29.84 - $44.08 $24,498 - $36,189
821 Added 102.63%
1,621 $54,000
Q3 2017

Nov 13, 2017

BUY
$15.81 - $24.01 $12,648 - $19,208
800
800 $19,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.